Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients
The role of prophylactic central lymph node dissection (pCLND) in the treatment of differentiated thyroid cancer (DTC) is controversial and still a matter of debate. The primary outcome of our study was to assess whether pCLND is effective in reducing the incidence of recurrent disease, and the seco...
Main Authors: | Fabio Medas, Gian Luigi Canu, Federico Cappellacci, Giacomo Anedda, Giovanni Conzo, Enrico Erdas, Pietro Giorgio Calò |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1658 |
Similar Items
-
Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases
by: Fabio Medas, et al.
Published: (2020-08-01) -
Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
by: Marco Roscigno, et al.
Published: (2018-09-01) -
Utilization Patterns of Lymph Node Dissection in Endometrial Cancer Patients Without Distant Metastasis in the United States
by: Alyea, Jennifer Marie
Published: (2021) -
Is prophylactic lateral lymph node dissection needed for lower rectal cancer? A single-center retrospective study
by: Hiroka Kondo, et al.
Published: (2021-05-01) -
Necessity of Low Partial Axillary Lymph Node Dissection for Breast Cancer Patients with Negative Result of Sentinel Lymph Node Biopsy
by: LIU Xuan, et al.
Published: (2018-12-01)